In the U.S., opioid-maker Purdue is bankrupt. Its global counterparts make millions.
At home in the United States, Purdue Pharma, the drugmaker accused of fueling the opioid crisis through its aggressive marketing of highly addictive pain pills, is bankrupt and facing thousands of